<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Delayed emergence and emergence delirium in adults
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Delayed emergence and emergence delirium in adults
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Delayed emergence and emergence delirium in adults
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sher-Lu Pai, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Natalie F Holt, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Nancy A Nussmeier, MD, FAHA
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jun 23, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H3899459550">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Failure to return to normal consciousness in a timely fashion following administration of general anesthesia may manifest as delayed emergence or emergence delirium. In most cases, these conditions are temporary and gradually resolve as anesthetic agents are metabolized and eliminated. Rarely, the cause is a serious medical or neurologic condition that requires urgent intervention.
        </p>
        <p>
         This topic will review the causes and management of delayed emergence and emergence delirium after general anesthesia. Management of persistent postoperative delirium is addressed separately. (See
         <a class="medical medical_review" href="/z/d/html/4823.html" rel="external">
          "Delirium and acute confusional states: Prevention, treatment, and prognosis", section on 'Management'
         </a>
         .)
        </p>
        <p>
         Other problems that occur in the post-anesthesia care unit (PACU) are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/14946.html" rel="external">
          "Overview of post-anesthetic care for adult patients"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3387197031">
         <span class="h1">
          NORMAL EMERGENCE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Emergence is the gradual return of consciousness after discontinuing administration of anesthetic and adjuvant agents at the end of the surgical procedure. Most patients transition smoothly from a surgical anesthetic state to an awake state with intact protective reflexes [
         <a href="#rid1">
          1
         </a>
         ]. After emergence in the operating room, transport to the post-anesthesia care unit (PACU) is typically accomplished when the patient has been extubated and is breathing spontaneously with adequate oxygenation and ventilation, is hemodynamically stable, and can be aroused to follow simple verbal commands (eg, eye opening or hand squeezing).
        </p>
        <p>
         Most patients become more fully conscious (ie, awake and aware of surroundings and identity) within approximately 15 minutes of extubation, and all patients should be responsive within 60 minutes after the last administration of any sedative, opioid, or anesthetic agent [
         <a href="#rid2">
          2-4
         </a>
         ]. However, the time required for return of consciousness varies depending on the specific anesthetic and analgesic agents employed (including their dosing, duration, and time since last administration) (see
         <a class="local">
          'Risk factors for prolonged drug effects'
         </a>
         below); the type and duration of the surgical procedure; and the patient's preoperative physical and mental status. Evidence also suggests that recovery of consciousness and loss of consciousness are different processes with specific mechanisms in the brain, and that return of consciousness is partly dependent on external and internal stimuli [
         <a href="#rid5">
          5-7
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2545165333">
         <span class="h1">
          DELAYED EMERGENCE
         </span>
        </p>
        <p class="headingAnchor" id="H654187917">
         <span class="h2">
          Initial management
         </span>
         <span class="headingEndMark">
          —
         </span>
         After extubation, patients with excessive somnolence are frequently stimulated to assess level of sedation, encourage adequate ventilation, and reestablish orientation. Typically, these measures result in a gradual return to full consciousness. (See
         <a class="medical medical_review" href="/z/d/html/96308.html" rel="external">
          "Maintenance of general anesthesia: Overview", section on 'Transition to the emergence phase'
         </a>
         .)
        </p>
        <p>
         If the patient remains unresponsive or heavily sedated 30 to 60 minutes after last administration of any anesthetic or adjuvant agent, further evaluation and treatment target the most common as well as the most serious conditions  (
         <a class="graphic graphic_table graphicRef106211" href="/z/d/graphic/106211.html" rel="external">
          table 1
         </a>
         ). All possibilities should be considered quickly and simultaneously to eliminate those causes which might require urgent attention (eg, stroke)  (
         <a class="graphic graphic_table graphicRef106223" href="/z/d/graphic/106223.html" rel="external">
          table 2
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H1984581323">
         <span class="h2">
          Consider prolonged drug effects
         </span>
         <span class="headingEndMark">
          —
         </span>
         Residual effect of one or more anesthetic or adjuvant agents is the most common cause of delayed emergence. Residual effect of a neuromuscular blocking agent (NMBA) should also be considered; muscle weakness may result in hypoventilation, causing hypoxemia and/or hypercapnia, which may further exacerbate sedation.
        </p>
        <p>
         An assessment should be made of the total and most recent doses of each anesthetic and adjuvant agent. Occasionally, a dosing error or accidental administration of an unintended anesthetic or adjuvant drug (eg, a syringe swap) may contribute to delayed emergence.
        </p>
        <p class="headingAnchor" id="H1347519796">
         <span class="h3">
          Risk factors for prolonged drug effects
         </span>
         <span class="headingEndMark">
          —
         </span>
         The following drug-drug interactions
         <strong>
         </strong>
         may exacerbate residual drug effects and delay emergence:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Combinations of anesthetic and adjuvant agents
         </strong>
         – When anesthetic drugs from different classes are combined, the central nervous system (CNS) effects are often synergistic. Synergy is particularly common when drugs acting primarily on GABA
         <sub>
          A
         </sub>
         receptors (eg,
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         ,
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         ,
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          etomidate
         </a>
         ) are combined with drugs acting on other receptor types [
         <a href="#rid8">
          8
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/94533.html" rel="external">
          "General anesthesia: Intravenous induction agents"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preoperative prescription and other drugs
         </strong>
         – Potentiation of CNS effects may also occur due to interactions of anesthetic agents with preoperative prescription drugs, supplements, recreational drugs, or alcohol  (
         <a class="graphic graphic_table graphicRef80618" href="/z/d/graphic/80618.html" rel="external">
          table 3
         </a>
         ).
        </p>
        <p>
        </p>
        <p>
         Several conditions may alter drug metabolism, elimination, or sensitivity and contribute to delayed emergence:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hepatic or renal insufficiency
         </strong>
         – In patients with renal or hepatic insufficiency, decreased drug metabolism and clearance result in an increased duration of action for most intravenous (IV) anesthetic and adjuvant agents [
         <a href="#rid9">
          9,10
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Age and weight
         </strong>
         – Age-related changes in pharmacodynamics and pharmacokinetics intensify and prolong CNS effects of anesthetic and adjuvant agents in older adults. (See
         <a class="medical medical_review" href="/z/d/html/14931.html" rel="external">
          "Anesthesia for the older adult"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Standard drug dosing in patients with very low body weight may result in absolute overdose, while relative overdose is common in patients with obesity who receive weight-based dosing of anesthetic agents. (See
         <a class="medical medical_review" href="/z/d/html/14932.html" rel="external">
          "Anesthesia for the patient with obesity", section on 'Dosing anesthetic drugs'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hypothermia
         </strong>
         – Hypothermia slows metabolism and elimination of most anesthetic and adjuvant agents. (See
         <a class="local">
          'Consider temperature and metabolic derangements'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hypothyroidism
         </strong>
         – Severely hypothyroid patients have impaired ventilatory drive and respiratory muscle weakness, which renders them more sensitive to the effects of sedatives, opioids, and neuromuscular blocking agents [
         <a href="#rid11">
          11-15
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7865.html" rel="external">
          "Respiratory function in thyroid disease", section on 'Hypothyroidism'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/91383.html" rel="external">
          "Anesthesia for patients with thyroid disease and for patients who undergo thyroid or parathyroid surgery", section on 'Hypothyroidism'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1096447307">
         <span class="h3">
          Opioids
         </span>
         <span class="headingEndMark">
          —
         </span>
         Opioids may contribute to delayed emergence because opioid sedative effects are synergistic with all other anesthetic and adjuvant agents. In addition, hypercapnia due to opioid-induced hypoventilation may further exacerbate sedation. A finding of miosis and bradypnea along with sedation suggests that opioids may be contributing to delayed emergence, particularly if high doses or a very potent opioid was administered.
        </p>
        <p>
         If opioid overdose is the most likely cause of heavy sedation, then a small dose of IV
         <a class="drug drug_general" data-topicid="9678" href="/z/d/drug information/9678.html" rel="external">
          naloxone
         </a>
         40 to 80 mcg may be administered. Administration of naloxone may avoid reintubation, and also rules out opioid-induced alteration in mental status to allow evaluation of other possible causes. Repeat 40 mcg doses of naloxone may be administered at two- to five-minute intervals until the patient is responsive, without evidence of respiratory depression. The half-life of naloxone is 1 to 1.5 hours, which may be shorter than the half-life of the opioid being reversed. In rare cases, a continuous infusion of naloxone is necessary to treat recurrent respiratory depression, with close observation and titration of the infusion rate according to patient response  (
         <a class="graphic graphic_table graphicRef106215" href="/z/d/graphic/106215.html" rel="external">
          table 4
         </a>
         ). The effective dose varies, depending on the amount of opioid the patient has received, the patient's weight, and the degree of opioid penetrance into the CNS [
         <a href="#rid16">
          16
         </a>
         ]. Naloxone is always carefully titrated to effect. Potential adverse effects include acute severe pain due to sudden reversal of analgesic effects of the opioid [
         <a href="#rid17">
          17
         </a>
         ], as well as uncommon severe adverse cardiopulmonary effects (eg, arrhythmias [
         <a href="#rid18">
          18-21
         </a>
         ], severe hypertension [
         <a href="#rid18">
          18,22-25
         </a>
         ], flash pulmonary edema [
         <a href="#rid18">
          18,26-32
         </a>
         ]). Massive release of catecholamines is the likely cause [
         <a href="#rid17">
          17,33
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/94348.html" rel="external">
          "Respiratory problems in the post-anesthesia care unit (PACU)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H586428613">
         <span class="h3">
          Benzodiazepines
         </span>
         <span class="headingEndMark">
          —
         </span>
         Sedative and respiratory-depressant effects of benzodiazepines are synergistic with other anesthetic and adjuvant agents, particularly when
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         is combined with
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         [
         <a href="#rid8">
          8
         </a>
         ]. Benzodiazepines are also associated with adverse effects such as amnesia, drowsiness, and cognitive dysfunction, as well as an unpredictable and relatively high risk of paradoxical reactions, such as irritability and aggressiveness during emergence [
         <a href="#rid34">
          34,35
         </a>
         ]. (See
         <a class="local">
          'Risk factors for prolonged drug effects'
         </a>
         above.)
        </p>
        <p>
         In rare cases,
         <a class="drug drug_general" data-topicid="8456" href="/z/d/drug information/8456.html" rel="external">
          flumazenil
         </a>
         is administered if a high dose of
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         or longer-acting benzodiazepine (eg,
         <a class="drug drug_general" data-topicid="9573" href="/z/d/drug information/9573.html" rel="external">
          lorazepam
         </a>
         ) is the most likely cause of excessive sedation and severe respiratory depression  (
         <a class="graphic graphic_table graphicRef106215" href="/z/d/graphic/106215.html" rel="external">
          table 4
         </a>
         ) [
         <a href="#rid34">
          34
         </a>
         ]. The initial adult dose of flumazenil is 0.2 mg IV over 30 seconds. Repeated doses of 0.2 mg may be given until the desired effect is achieved, up to a maximum dose of 1 mg. Since flumazenil may be shorter acting than the benzodiazepine being reversed, the patient is closely monitored for recurrence of sedation and/or hypoventilation. Flumazenil dosing may be repeated, but no more than 3 mg may be administered within a given hour. (See
         <a class="medical medical_review" href="/z/d/html/314.html" rel="external">
          "Benzodiazepine poisoning", section on 'Role of antidote (flumazenil)'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2670212005">
         <span class="h3">
          Sedative-hypnotic agents
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although termination of sedation is typically rapid after discontinuation of IV sedative-hypnotic agents, their effects are synergistic with opioids and other anesthetic agents. (See
         <a class="local">
          'Risk factors for prolonged drug effects'
         </a>
         above.)
        </p>
        <p>
         Recovery from an IV sedative-hypnotic infusion depends on the agent's context-sensitive half time (the time required for plasma concentrations to decline by 50 percent following discontinuation of a steady-state infusion), as well as the duration of infusion. For example, recovery time and awakening typically occur &lt;25 minutes after discontinuation of a
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         infusion administered at maintenance doses for three hours [
         <a href="#rid36">
          36
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/96308.html" rel="external">
          "Maintenance of general anesthesia: Overview", section on 'Sedative-hypnotic agent: Propofol'
         </a>
         .)
        </p>
        <p>
         <a class="drug drug_general" data-topicid="8897" href="/z/d/drug information/8897.html" rel="external">
          Dexmedetomidine
         </a>
         is a highly selective alpha
         <sub>
          2
         </sub>
         agonist acting on receptors in the brain and spinal cord that may be administered by infusion in the perioperative period to take advantage of its analgesic, sedative, anxiolytic, and sympatholytic properties. Resolution occurs gradually after discontinuation of dexmedetomidine, such that residual sedation, as well as hemodynamic depression of heart rate and blood pressure, may persist in the early postoperative period [
         <a href="#rid37">
          37
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/96308.html" rel="external">
          "Maintenance of general anesthesia: Overview", section on 'Dexmedetomidine'
         </a>
         .)
        </p>
        <p>
         There are no reversal agents for any IV sedative-hypnotic. Somnolent patients are frequently stimulated to encourage ventilation and prevent exacerbation of sedation due to hypercapnia.
        </p>
        <p class="headingAnchor" id="H2615081435">
         <span class="h3">
          Volatile inhalation anesthetics
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although termination of sedation is typically rapid after discontinuation of an inhalation anesthetic, elimination may be prolonged with longer duration of administration [
         <a href="#rid38">
          38
         </a>
         ], low minute ventilation, and/or low cardiac output.
         <a class="drug drug_general" data-topicid="8992" href="/z/d/drug information/8992.html" rel="external">
          Isoflurane
         </a>
         is eliminated more slowly than
         <a class="drug drug_general" data-topicid="9887" href="/z/d/drug information/9887.html" rel="external">
          sevoflurane
         </a>
         or
         <a class="drug drug_general" data-topicid="8891" href="/z/d/drug information/8891.html" rel="external">
          desflurane
         </a>
         . However, in one study of nearly 1500 patients, isoflurane prolonged emergence by only two minutes, and did not prolong length of stay in the PACU [
         <a href="#rid39">
          39
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/96308.html" rel="external">
          "Maintenance of general anesthesia: Overview", section on 'Transition to the emergence phase'
         </a>
         .)
        </p>
        <p>
         Although inhalation agents are unlikely to be a factor for excessive somnolence for more than a few minutes after initial emergence from general anesthesia, their effects are synergistic with opioids and other anesthetic agents (see
         <a class="local">
          'Risk factors for prolonged drug effects'
         </a>
         above). Thus, patients are stimulated frequently to encourage adequate ventilation during transport from the operating room and the first several minutes in the PACU, thereby avoiding hypoventilation and elimination of any residual inhalation anesthetic agent.
        </p>
        <p class="headingAnchor" id="H2967836132">
         <span class="h3">
          Anticholinergic agents
         </span>
         <span class="headingEndMark">
          —
         </span>
         An overdose of
         <a class="drug drug_general" data-topicid="9915" href="/z/d/drug information/9915.html" rel="external">
          scopolamine
         </a>
         ,
         <a class="drug drug_general" data-topicid="8983" href="/z/d/drug information/8983.html" rel="external">
          atropine
         </a>
         , or a combination of agents with anticholinergic activity rarely produces coma  (
         <a class="graphic graphic_table graphicRef100289" href="/z/d/graphic/100289.html" rel="external">
          table 5
         </a>
         ). Delirium and other features of anticholinergic intoxication such as mydriasis, hyperthermia, redness, or anhidrosis are more likely manifestations of anticholinergic overdose, especially in older adult patients [
         <a href="#rid40">
          40,41
         </a>
         ]. (See
         <a class="local">
          'Emergence delirium'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/305.html" rel="external">
          "Anticholinergic poisoning", section on 'Clinical features of overdose'
         </a>
         .)
        </p>
        <p>
         <a class="drug drug_general" data-topicid="9770" href="/z/d/drug information/9770.html" rel="external">
          Physostigmine
         </a>
         0.5 to 2 mg IV (or 25 to 50 mcg/kg) may be administered by slow IV push if anticholinergic overdose is strongly suspected, with continuous electrocardiographic monitoring to detect severe bradycardia, as well as close observation for seizures or bronchospasm  (
         <a class="graphic graphic_table graphicRef106215" href="/z/d/graphic/106215.html" rel="external">
          table 4
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/305.html" rel="external">
          "Anticholinergic poisoning", section on 'Antidotal therapy with physostigmine for severe toxicity'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1348059436">
         <span class="h3">
          Neuromuscular blocking agents
         </span>
         <span class="headingEndMark">
          —
         </span>
         Residual effect of NMBAs due to incomplete reversal is common in the PACU [
         <a href="#rid42">
          42-45
         </a>
         ]. Consequent muscle weakness and hypoventilation may result in hypercapnia that exacerbates sedation, and also interfere with elimination of residual inhalation anesthetics.
        </p>
        <p>
         A pharmacologic reversal agent (eg,
         <a class="drug drug_general" data-topicid="9693" href="/z/d/drug information/9693.html" rel="external">
          neostigmine
         </a>
         [up to 5 mg] given with
         <a class="drug drug_general" data-topicid="8496" href="/z/d/drug information/8496.html" rel="external">
          glycopyrrolate
         </a>
         [up to 1 mg], or
         <a class="drug drug_general" data-topicid="105866" href="/z/d/drug information/105866.html" rel="external">
          sugammadex
         </a>
         2 mg/kg) is administered if residual blockade is suspected or confirmed with a peripheral nerve stimulator. If muscle weakness persists after administration of maximum doses of NMBA reversal agents, temporary controlled mechanical ventilation may be necessary. (See
         <a class="medical medical_review" href="/z/d/html/4401.html" rel="external">
          "Overview of the management of postoperative pulmonary complications"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3074229895">
         <span class="h2">
          Consider hypoxemia and/or hypercapnia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Arterial blood gases are measured in patients with delayed emergence, and hypoxemia and/or hypercapnia are promptly treated. Hypoxemia is detected with pulse oximetry, but this is an insensitive monitor of hypoventilation and hypercapnia because supplemental oxygen is administered to most patients. Although hypercapnia is detected with continuous monitoring of end-tidal carbon dioxide (ETCO
         <sub>
          2
         </sub>
         ) while the patient is in the operating room, capnography may not be available in the PACU. Treatment of respiratory problems that cause hypoxemia and/or hypercapnia is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/94348.html" rel="external">
          "Respiratory problems in the post-anesthesia care unit (PACU)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H73019765">
         <span class="h2">
          Consider temperature and metabolic derangements
         </span>
         <span class="headingEndMark">
          —
         </span>
         Temperature is measured, and standard point-of-care laboratory tests for glucose and electrolytes are obtained. Hypothermia, hyperthermia, or metabolic derangements may cause somnolence.
        </p>
        <p>
         Temperature derangements are promptly treated.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hypothermia
         </strong>
         – Even mild hypothermia &lt;35°C may impair consciousness and potentiate CNS-depressant effects of anesthetic agents. Warming in the PACU is typically achieved using forced-air warming devices. If temperature is &lt;33°C, a period of controlled mechanical ventilation is typically necessary while the patient is rewarmed. (See
         <a class="medical medical_review" href="/z/d/html/94588.html" rel="external">
          "Perioperative temperature management", section on 'Hypothermia'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The most common cause of hypothermia is environmental exposure that occurred in the operating room, but certain medical conditions may exacerbate it (eg, hypoglycemia, adrenal insufficiency, sepsis, hypothyroidism). (See
         <a class="medical medical_review" href="/z/d/html/94588.html" rel="external">
          "Perioperative temperature management", section on 'Intraoperative hypothermia'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hyperthermia
         </strong>
         – Elevated temperature &gt;38°C may cause mental status changes. The most common causes of hyperthermia are accidental overwarming and postoperative fever. Blankets are removed, evaporative cooling measures may be employed, and
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         650 mg is administered if fever is the cause. (See
         <a class="medical medical_review" href="/z/d/html/94588.html" rel="external">
          "Perioperative temperature management", section on 'Fever or hyperthermia'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Malignant hyperthermia should also be considered, particularly if sinus tachycardia and/or masseter or generalized muscle rigidity are present, or if laboratory studies reveal hypercarbia, metabolic acidosis, and/or hyperkalemia. (See
         <a class="medical medical_review" href="/z/d/html/401.html" rel="external">
          "Malignant hyperthermia: Diagnosis and management of acute crisis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Other details regarding evaluation and management of postoperative fever are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2886.html" rel="external">
          "Fever in the surgical patient"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Glucose and electrolyte levels are checked and abnormalities are promptly treated.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Glucose
         </strong>
         – Either hypoglycemia or hyperglycemia may cause sedation requiring prompt treatment.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Acute severe hypoglycemia (&lt;50 mg/dL) is treated with an IV bolus of 25 to 50 g of dextrose, followed by a continuous dextrose infusion, with measurement of blood glucose concentrations every 30 to 60 minutes. Reversal of CNS symptoms may lag behind normalization of glucose levels.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Treatment of severe hyperglycemia is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1795.html" rel="external">
          "Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Treatment"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Sodium
         </strong>
         – Treatment of hyponatremia and hypernatremia are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2350.html" rel="external">
          "Overview of the treatment of hyponatremia in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2339.html" rel="external">
          "Treatment of hypernatremia in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Perioperative hyponatremia may occur in patients with syndrome of inappropriate antidiuretic hormone secretion (SIADH) [
         <a href="#rid46">
          46
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/2374.html" rel="external">
          "Causes of hypotonic hyponatremia in adults"
         </a>
         ). Hyponatremia may also be caused by a nonconductive (ie, nonelectrolyte) irrigation solution used during hysteroscopy or transurethral resection of the prostate (TURP) or bladder (TURB). (See
         <a class="medical medical_review" href="/z/d/html/2363.html" rel="external">
          "Hyponatremia following transurethral resection, hysteroscopy, or other procedures involving electrolyte-free irrigation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Perioperative hypernatremia may occur due to infusion of large volumes of
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         or bicarbonate, intraoperative insensible water losses, or diabetes. (See
         <a class="medical medical_review" href="/z/d/html/2376.html" rel="external">
          "Etiology and evaluation of hypernatremia in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hypermagnesemia
         </strong>
         – Hypermagnesemia (&gt;4 mEq/L) typically resolves with cessation of magnesium therapy (eg, IV magnesium infusion for treatment of eclampsia or preeclampsia). In the setting of renal insufficiency, patients with hypermagnesemia are treated with isotonic IV fluids plus a loop diuretic (eg,
         <a class="drug drug_general" data-topicid="8482" href="/z/d/drug information/8482.html" rel="external">
          furosemide
         </a>
         ) in addition to discontinuing any magnesium therapy; dialysis may be required. (See
         <a class="medical medical_review" href="/z/d/html/831.html" rel="external">
          "Hypermagnesemia: Causes, symptoms, and treatment"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hypercalcemia
         </strong>
         – Postoperative hypercalcemia may occur in patients who had surgery for hyperparathyroidism or malignancy; treatment is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/850.html" rel="external">
          "Treatment of hypercalcemia"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H314773909">
         <span class="h2">
          Consider neurologic disorders
         </span>
         <span class="headingEndMark">
          —
         </span>
         A basic neurologic examination is performed as soon as feasible when emergence is delayed  (
         <a class="graphic graphic_table graphicRef106223" href="/z/d/graphic/106223.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid47">
          47,48
         </a>
         ]. For patients with reduced level of consciousness, the neurologic examination assesses spontaneous behavior and responses to stimuli, as well as motor responses and cranial nerve function (eg, pupillary reactivity, eye movements)  (
         <a class="graphic graphic_figure graphicRef54134" href="/z/d/graphic/54134.html" rel="external">
          figure 1
         </a>
         ). For unresponsive or poorly responsive patients, the Glasgow coma scale (GCS) may be used to gauge the severity of stupor or coma  (
         <a class="graphic graphic_table graphicRef81854" href="/z/d/graphic/81854.html" rel="external">
          table 6
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/5104.html" rel="external">
          "Stupor and coma in adults", section on 'Neurologic examination'
         </a>
         .)
        </p>
        <p>
         Neurologic causes of delayed emergence are more common in patients undergoing specific types of surgery, as noted below, particularly after craniotomy for neurosurgical procedures (eg, intracranial vascular procedures, tumor resection, evacuation of hematoma, trauma). In such cases, evaluation should include the surgeon to rule out possible surgical complications. (See
         <a class="medical medical_review" href="/z/d/html/93391.html" rel="external">
          "Anesthesia for craniotomy in adults", section on 'Delayed emergence'
         </a>
         .)
        </p>
        <p>
         Depending on the results of the initial examination and after assessment of possible causes as noted above, an urgent neurologic consultation and neuroimaging study may be requested to evaluate the possibility of an acute intracranial event such as:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acute stroke
         </strong>
         – Acute perioperative stroke may be caused by cerebral ischemia or intracranial hemorrhage. Although perioperative stroke is uncommon in patients undergoing noncardiac surgery, those undergoing carotid endarterectomy, aortic or peripheral vascular surgery, or resection of head and neck tumors are at higher risk than other surgical patients [
         <a href="#rid49">
          49-52
         </a>
         ]. In some cases, the event may not be apparent in the PACU, but occurs a few hours or days later. The evaluation and management of acute stroke is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/114426.html" rel="external">
          "Perioperative stroke following noncardiac, noncarotid, and nonneurologic surgery"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1126.html" rel="external">
          "Initial assessment and management of acute stroke"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Seizures
         </strong>
         – A postictal state or nonconvulsive seizures are unusual causes of obtundation in the PACU.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Perioperative seizures occasionally occur due to epilepsy, acute stroke, surgery for traumatic brain injury, intracranial tumor, cerebral aneurysm or arteriovenous malformation, local anesthetic or other drug toxicity, or alcohol withdrawal  (
         <a class="graphic graphic_table graphicRef61807" href="/z/d/graphic/61807.html" rel="external">
          table 7
         </a>
         ). Treatment of convulsive seizures is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/96933.html" rel="external">
          "Convulsive status epilepticus in adults: Management", section on 'Emergency antiseizure treatment'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Evaluation and management of nonconvulsive seizures are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/14103.html" rel="external">
          "Nonconvulsive status epilepticus: Classification, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hypoxic-ischemic encephalopathy
         </strong>
         – Hypoxic-ischemic encephalopathy may follow a precipitating perioperative event such as cardiac arrest or profound hypotension. Evaluation and treatment are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4833.html" rel="external">
          "Hypoxic-ischemic brain injury in adults: Evaluation and prognosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Elevated intracranial pressure
         </strong>
         – Acute elevation of intracranial pressure may occur after surgery for intracranial hematoma or tumor, or because of cerebral edema (eg, severe traumatic brain injury, large cerebral infarction, acute hypoxic ischemic encephalopathy), malfunctioning ventriculoperitoneal (VP) shunt, or obstruction of cerebral venous outflow (eg, venous sinus thrombosis, jugular vein compression, neck surgery). Evaluation and treatment are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1659.html" rel="external">
          "Evaluation and management of elevated intracranial pressure in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prior neurologic deficits
         </strong>
         – Transient focal neurologic deficits may occur after sedation or general anesthesia in patients with a prior history of neurologic insult from stroke or other cause; this phenomenon is known as differential awakening. Such deficits typically improve over 30 minutes to several hours, but multidisciplinary evaluation is required. (See
         <a class="medical medical_review" href="/z/d/html/93391.html" rel="external">
          "Anesthesia for craniotomy in adults", section on 'Differential emergence or awakening'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hyperperfusion syndrome
         </strong>
         – Cerebral hyperperfusion syndrome is a rare sequela of carotid endarterectomy. (See
         <a class="medical medical_review" href="/z/d/html/15843.html" rel="external">
          "Complications of carotid endarterectomy", section on 'Hyperperfusion syndrome'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Air embolism or fat embolism syndrome
         </strong>
         – Focal neurologic deficits or mental status changes may occur shortly after surgery due to arterial air embolism [
         <a href="#rid53">
          53
         </a>
         ] or fat embolism syndrome [
         <a href="#rid54">
          54
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8263.html" rel="external">
          "Air embolism", section on 'Surgery and trauma'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1602.html" rel="external">
          "Fat embolism syndrome"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1942104686">
         <span class="h1">
          EMERGENCE DELIRIUM
         </span>
        </p>
        <p class="headingAnchor" id="H1466707146">
         <span class="h2">
          Clinical features
         </span>
         <span class="headingEndMark">
          —
         </span>
         A brief period of agitation is common during emergence from general anesthesia. As patients transition through a stage of delirium during initial emergence, they may exhibit agitation, hyperexcitability, disinhibition, crying, restlessness, and mental confusion [
         <a href="#rid55">
          55-58
         </a>
         ]. Terms to describe this phase include emergence excitement, emergence agitation, and emergence delirium. This intraoperative stage of emergence is usually very brief (a few minutes), and often resolves quickly following removal of a noxious stimulus, such as the endotracheal tube. A brief period of emergence delirium is particularly common in children. (See
         <a class="medical medical_review" href="/z/d/html/94537.html" rel="external">
          "Emergence from general anesthesia", section on 'Severe agitation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94564.html" rel="external">
          "Emergence delirium and agitation in children"
         </a>
         .)
        </p>
        <p>
         In one prospective observational study that employed the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) criteria in 400 adult patients, intraoperative agitation during emergence occurred in 19 percent [
         <a href="#rid56">
          56
         </a>
         ]. A prospective observational study that employed a different method of assessment, the Richmond Agitation-Sedation Scale (RASS) in 1970 adult patients, 3.7 percent had evidence of emergence delirium in the operating room immediately after extubation, while only 1.3 percent remained delirious shortly after admission to the post-anesthesia care unit (PACU) [
         <a href="#rid58">
          58
         </a>
         ]. Another observational study used the Nursing Delirium Screening Scale in 1000 patients undergoing orthopedic or abdominal surgery, noting "inadequate emergence," (defined as a score ≥2) in 10 percent upon arrival in the PACU, although 2 percent had a score ≥2 before the surgical procedure [
         <a href="#rid38">
          38
         </a>
         ]. In this study, patients with positive scores for delirium had a longer duration of anesthesia.
        </p>
        <p>
         In some patients, postoperative delirium persists or reoccurs after initial emergence from anesthesia, or only becomes evident in the PACU [
         <a href="#rid38">
          38,59,60
         </a>
         ]. A lucid period usually is evident after initial emergence from general anesthesia, but not always. Postoperative delirium may manifest as agitation (hyperactive subtype) or as somnolence with altered mental status (hypoactive subtype) occurring in the postoperative period after initial emergence from general anesthesia [
         <a href="#rid56">
          56,61
         </a>
         ]. Hyperactive delirium is more easily detected due to overt agitation, hyperexcitability, disinhibition, crying, restlessness, and mental confusion; some patients fluctuate between the hyper- and hypoactive subtypes [
         <a href="#rid62">
          62
         </a>
         ]. In a study that employed the CAM-ICU criteria, 31 percent of 400 adult patients were delirious upon admission to the PACU after general anesthesia [
         <a href="#rid56">
          56
         </a>
         ]. Approximately one-half of these patients exhibited hyperactive delirium, while one-half had the hypoactive subtype. The incidence of delirium decreased to 15 percent after 30 minutes, 8 percent after 60 minutes, and only 4 percent at the time of PACU discharge. Most of those with persistent delirium throughout their PACU stay had the hypoactive subtype (92 percent), and all met other criteria for discharge from the PACU [
         <a href="#rid56">
          56
         </a>
         ]. Pediatric patients have a higher incidence of delirium during and shortly after emergence from general anesthesia compared with adults. (See
         <a class="medical medical_review" href="/z/d/html/94564.html" rel="external">
          "Emergence delirium and agitation in children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2727864216">
         <span class="h2">
          Evaluation and treatment
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hypoactive emergence delirium shares similar causes with delayed emergence; thus, evaluation and treatment of these entities are similar in the PACU setting  (
         <a class="graphic graphic_table graphicRef106211" href="/z/d/graphic/106211.html" rel="external">
          table 1
         </a>
         and
         <a class="graphic graphic_table graphicRef106223" href="/z/d/graphic/106223.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="local">
          'Delayed emergence'
         </a>
         above.)
        </p>
        <p>
         In patients with hyperactive emergence delirium, other causes include acute pain due to surgery or other discomfort (eg, bladder distention) or panic due to dyspnea and respiratory distress caused by residual neuromuscular blockade. (See
         <a class="local">
          'Neuromuscular blocking agents'
         </a>
         above.)
        </p>
        <p>
         Initial management of emergence delirium and/or agitation includes:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Reassurance and reorientation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Treatment of acute pain. However, the clinical effect of each opioid dose is closely monitored because opioids may precipitate delirium [
         <a href="#rid56">
          56,63
         </a>
         ]. Nonopioid agents and techniques are preferred, if effective. (See
         <a class="medical medical_review" href="/z/d/html/4823.html" rel="external">
          "Delirium and acute confusional states: Prevention, treatment, and prognosis", section on 'Prevention'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4823.html" rel="external">
          "Delirium and acute confusional states: Prevention, treatment, and prognosis", section on 'Management'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Treatment of other discomfort (bladder distention, hypothermia). (See
         <a class="medical medical_review" href="/z/d/html/14946.html" rel="external">
          "Overview of post-anesthetic care for adult patients"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Laboratory testing to determine if hypoxemia, hypercarbia, hypoglycemia, or electrolyte imbalances are present.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Consideration of effects of certain residual anesthetic agents (eg, benzodiazepines, opioids,
         <a class="drug drug_general" data-topicid="9915" href="/z/d/drug information/9915.html" rel="external">
          scopolamine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9369" href="/z/d/drug information/9369.html" rel="external">
          diphenhydramine
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_general" data-topicid="8897" href="/z/d/drug information/8897.html" rel="external">
          Dexmedetomidine
         </a>
         – Some studies suggest that intraoperative administration of dexmedetomidine ameliorates or reduces the incidence of hyperactive delirium [
         <a href="#rid64">
          64-68
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/118691.html" rel="external">
          "Perioperative neurocognitive disorders in adults: Risk factors and mitigation strategies", section on 'Intravenous agents associated with lower risk'
         </a>
         ). A 2022 meta-analysis of randomized trials in patients undergoing noncardiac nonneurologic surgery (2676 patients; 33 studies) noted that intraoperative dexmedetomidine administration was associated with reduced incidence of emergence agitation (risk ratio [RR] 0.38, 95% CI 0.29-0.52) compared with placebo [
         <a href="#rid68">
          68
         </a>
         ]. Also, a lower incidence of clinically significant pain (RR 0.50, 95% CI 0.32-0.80), nausea and vomiting (RR 0.54, 95% Ci 0.0.33-0.86), shivering (RR 0.24, 95% CI 0.12-0.49), and coughing (RR 0.69, 95% CI 0.61-0.79) was noted in patients receiving dexmedetomidine. However, hypotension in the PACU was more likely in those receiving dexmedetomidine (RR 5.39, 95% CI 1.12-5.89) [
         <a href="#rid68">
          68
         </a>
         ]. Also, time to extubation was slightly longer in patients receiving dexmedetomidine (mean difference one minute, 95% CI 0.32-1.68 minutes), although the time to PACU discharge was not prolonged. We do not routinely use dexmedetomidine to minimize emergence agitation due to increased risk for hypotension and slight prolongation of time to emergence, but we may select this agent for airway or other procedures to minimize postoperative coughing.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          Ketamine
         </a>
         – Although the psychotomimetic side effects of ketamine may present as emergence delirium (eg, hallucinations, nightmares, vivid dreams), this is not a consistent phenomenon [
         <a href="#rid69">
          69-73
         </a>
         ]. We avoid routine co-administration of preoperative benzodiazepine since this is a predictor of emergence delirium in the recovery room [
         <a href="#rid74">
          74
         </a>
         ]. (See
         <a class="local">
          'Consider prolonged drug effects'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Consideration of preoperative substance abuse (eg, alcohol, amphetamines, cocaine, cannabinoids). If suspected, a toxicology screen may provide useful information. (See
         <a class="medical medical_review" href="/z/d/html/13846.html" rel="external">
          "Testing for drugs of abuse (DOAs)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Consideration of other drug toxicity, including agents that may cause serotonin syndrome  (
         <a class="graphic graphic_table graphicRef70449" href="/z/d/graphic/70449.html" rel="external">
          table 8
         </a>
         and
         <a class="graphic graphic_table graphicRef71268" href="/z/d/graphic/71268.html" rel="external">
          table 9
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/4824.html" rel="external">
          "Diagnosis of delirium and confusional states"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/301.html" rel="external">
          "Serotonin syndrome (serotonin toxicity)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         In a severely agitated PACU patient, after treatment of reversible causes of delirium, and if redirection and reorientation have failed, administration of a small dose of
         <a class="drug drug_general" data-topicid="8516" href="/z/d/drug information/8516.html" rel="external">
          haloperidol
         </a>
         (eg, 0.5 to 2 mg) is reasonable, and this dose may be repeated (up to approximately 5 mg total dose). Because haloperidol does not worsen the overall course of delirium, we prefer it rather than a benzodiazepine to sedate a patient with severe agitation who is a danger to himself or others. (See
         <a class="medical medical_review" href="/z/d/html/1616.html" rel="external">
          "Sedative-analgesia in ventilated adults: Medication properties, dose regimens, and adverse effects"
         </a>
         .)
        </p>
        <p>
         However, prophylactic
         <a class="drug drug_general" data-topicid="8516" href="/z/d/drug information/8516.html" rel="external">
          haloperidol
         </a>
         to prevent delirium is not recommended. Antipsychotics are on the Beers criteria list as drugs to avoid in older adults (see
         <a class="medical medical_review" href="/z/d/html/3013.html" rel="external">
          "Drug prescribing for older adults", section on 'Beers criteria'
         </a>
         ). In one multicenter study, medical and surgical patients older than 70 years were randomized to receive haloperidol or placebo on top of nonpharmacologic strategies to prevent delirium [
         <a href="#rid75">
          75
         </a>
         ]. There were no differences in delirium incidence, duration, or severity. Similarly, other antipsychotics (either typical or atypical) have not altered delirium incidence, duration, or severity in either general medical or postoperative critically ill patients, and may confer harm [
         <a href="#rid76">
          76-78
         </a>
         ].
        </p>
        <p>
         A neurology consult is obtained if delirium is severe and persistent, although an acute intracranial event such as stroke is a rare cause. Delirium lasting hours or days is associated with older age, preoperative cognitive impairment, alcohol use, severe medical illness, and specific laboratory abnormalities (eg, sodium or glucose levels) [
         <a href="#rid79">
          79-84
         </a>
         ]. Delirium at the time of PACU discharge is predictive of persistent delirium later in the postoperative course, with outcomes that are worse than patients without this complication (eg, mortality, prolonged length-of-stay in the hospital, institutionalization at discharge) [
         <a href="#rid57">
          57,79,85-88
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4823.html" rel="external">
          "Delirium and acute confusional states: Prevention, treatment, and prognosis"
         </a>
         .)
        </p>
        <p>
         Mitigation strategies and management of persistent postoperative delirium are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/118691.html" rel="external">
          "Perioperative neurocognitive disorders in adults: Risk factors and mitigation strategies"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4823.html" rel="external">
          "Delirium and acute confusional states: Prevention, treatment, and prognosis", section on 'Management'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1376499071">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/111581.html" rel="external">
          "Society guideline links: Delirium and confusional states in older adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3514007350">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Delayed emergence
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Definition
         </strong>
         – Delayed emergence after general anesthesia is defined as a failure to return to a conscious state with intact protective reflexes within 60 minutes after last administration of any opioid, sedative-hypnotic, or other anesthetic agent. (See
         <a class="local">
          'Normal emergence'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Initial management
         </strong>
         – Patients with excessive somnolence are frequently stimulated to assess level of sedation, produce arousal, encourage adequate ventilation, and reestablish orientation. Further evaluation and treatment target the most common and serious conditions  (
         <a class="graphic graphic_table graphicRef106223" href="/z/d/graphic/106223.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="local">
          'Initial management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Management of residual effects of anesthetic agents
         </strong>
         – Delayed emergence or delirium is usually caused by residual effects of one or more anesthetic or adjuvant agents. (See
         <a class="local">
          'Consider prolonged drug effects'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Sedative-hypnotic agents
         </strong>
         – There are no reversal agents for sedative-hypnotic agents or volatile anesthetic agents. (See
         <a class="local">
          'Sedative-hypnotic agents'
         </a>
         above and
         <a class="local">
          'Volatile inhalation anesthetics'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Opioids
         </strong>
         – If opioid overdose is the most likely cause of heavy sedation and persistent bradypnea, we administer
         <a class="drug drug_general" data-topicid="9678" href="/z/d/drug information/9678.html" rel="external">
          naloxone
         </a>
         40 to 80 mcg, with titration of additional 40 mcg doses at two- to five-minute intervals until the patient is responsive without evidence of respiratory depression  (
         <a class="graphic graphic_table graphicRef106215" href="/z/d/graphic/106215.html" rel="external">
          table 4
         </a>
         ). Administration of naloxone may avoid reintubation and rules out opioid-induced sedation, allowing assessment for other possible causes of alteration in mental status. (See
         <a class="local">
          'Opioids'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Benzodiazepines
         </strong>
         – In rare cases, overdose of a benzodiazepine necessitates reversal with
         <a class="drug drug_general" data-topicid="8456" href="/z/d/drug information/8456.html" rel="external">
          flumazenil
         </a>
         , or overdose of anticholinergic agent(s) necessitates reversal with
         <a class="drug drug_general" data-topicid="9770" href="/z/d/drug information/9770.html" rel="external">
          physostigmine
         </a>
         (
         <a class="graphic graphic_table graphicRef106215" href="/z/d/graphic/106215.html" rel="external">
          table 4
         </a>
         ). (See
         <a class="local">
          'Benzodiazepines'
         </a>
         above and
         <a class="local">
          'Anticholinergic agents'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Neuromuscular blocking agents
         </strong>
         – Weakness due to residual effects of a neuromuscular blocking agent (NMBA) may contribute to delayed emergence by causing hypoventilation with hypercapnia, which exacerbates sedation and interferes with elimination of residual inhalation anesthetics. Reversal agents (eg,
         <a class="drug drug_general" data-topicid="9693" href="/z/d/drug information/9693.html" rel="external">
          neostigmine
         </a>
         given with
         <a class="drug drug_general" data-topicid="8496" href="/z/d/drug information/8496.html" rel="external">
          glycopyrrolate
         </a>
         , or
         <a class="drug drug_general" data-topicid="105866" href="/z/d/drug information/105866.html" rel="external">
          sugammadex
         </a>
         ) are administered if NMBA effect is suspected or confirmed with a peripheral nerve stimulator. (See
         <a class="local">
          'Neuromuscular blocking agents'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Management of other causes
         </strong>
         – Hypoxemia and/or hypercapnia, hypothermia or hyperthermia, hypoglycemia or hyperglycemia, and electrolyte imbalances are evaluated and promptly treated as possible causes of delayed emergence or delirium  (
         <a class="graphic graphic_table graphicRef106223" href="/z/d/graphic/106223.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="local">
          'Consider hypoxemia and/or hypercapnia'
         </a>
         above and
         <a class="local">
          'Consider temperature and metabolic derangements'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Treatment
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Nonpharmacologic treatment
         </strong>
         – Management of emergence or delirium agitation includes reassurance and reorientation, as well as treatment of acute pain and other discomfort (eg, bladder distention, hypothermia, weakness due to residual NMBA) and metabolic abnormalities. Other possible causes include preoperative substance abuse or other drug toxicity. (See
         <a class="local">
          'Emergence delirium'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Pharmacologic treatment
         </strong>
         – Administration of a small dose of
         <a class="drug drug_general" data-topicid="8516" href="/z/d/drug information/8516.html" rel="external">
          haloperidol
         </a>
         (eg, 0.5 to 2 mg) is reasonable in a severely agitated patient in the post-anesthesia care unit (PACU) after treatment of reversible causes of delirium, and this dose may be repeated (up to approximately 5 mg total dose) (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). Because haloperidol does not worsen the overall course of delirium, we prefer it rather than a benzodiazepine to sedate a patient with severe agitation who is a danger to himself or others. However, prophylactic haloperidol to prevent delirium is not recommended (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management of persistent delay in emergence or delirium
         </strong>
         – A basic neurologic examination is performed if delayed emergence or delirium persists after assessment for other causes  (
         <a class="graphic graphic_table graphicRef106223" href="/z/d/graphic/106223.html" rel="external">
          table 2
         </a>
         and
         <a class="graphic graphic_figure graphicRef54134" href="/z/d/graphic/54134.html" rel="external">
          figure 1
         </a>
         and
         <a class="graphic graphic_table graphicRef81854" href="/z/d/graphic/81854.html" rel="external">
          table 6
         </a>
         ). Urgent neurologic consultation and neuroimaging study are occasionally necessary to evaluate an acute intracranial event. (See
         <a class="local">
          'Consider neurologic disorders'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Causes and management of persistent delirium are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/118691.html" rel="external">
          "Perioperative neurocognitive disorders in adults: Risk factors and mitigation strategies"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4823.html" rel="external">
          "Delirium and acute confusional states: Prevention, treatment, and prognosis", section on 'Management'
         </a>
         .)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Brown EN, Lydic R, Schiff ND. General anesthesia, sleep, and coma. N Engl J Med 2010; 363:2638.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zelcer J, Wells DG. Anaesthetic-related recovery room complications. Anaesth Intensive Care 1987; 15:168.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frost EA. Differential diagnosis of delayed awakening from general anesthesia: a review. Middle East J Anaesthesiol 2014; 22:537.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pavlin DJ, Rapp SE, Polissar NL, et al. Factors affecting discharge time in adult outpatients. Anesth Analg 1998; 87:816.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Engbers F. Is unconsciousness simply the reverse of consciousness? Anaesthesia 2018; 73:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pandit JJ. Monitoring (un)consciousness: the implications of a new definition of 'anaesthesia'. Anaesthesia 2014; 69:801.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jung YS, Paik H, Min SH, et al. Calling the patient's own name facilitates recovery from general anaesthesia: a randomised double-blind trial. Anaesthesia 2017; 72:197.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hendrickx JF, Eger EI 2nd, Sonner JM, Shafer SL. Is synergy the rule? A review of anesthetic interactions producing hypnosis and immobility. Anesth Analg 2008; 107:494.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mcclain RL, Ramakrishna H, Aniskevich S III, et al. Anesthetic pharmacology and perioperative considerations for the end stage liver disease patient. Curr Clin Pharmacol 2015; 10:35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aniskevich S, Pai SL, Shine TS. Anesthetic pharmacology for kidney transplantation. Curr Clin Pharmacol 2015; 10:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smallridge RC. Metabolic and anatomic thyroid emergencies: a review. Crit Care Med 1992; 20:276.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abbott TR. Anaesthesia in untreated myxoedema. Report of two cases. Br J Anaesth 1967; 39:510.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim JM, Hackman L. Anesthesia for untreated hypothyroidism: report of three cases. Anesth Analg 1977; 56:299.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Datta D, Scalise P. Hypothyroidism and failure to wean in patients receiving prolonged mechanical ventilation at a regional weaning center. Chest 2004; 126:1307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lele AV, Clutter S, Price E, De Ruyter ML. Severe hypothyroidism presenting as myxedema coma in the postoperative period in a patient taking sunitinib: case report and review of literature. J Clin Anesth 2013; 25:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyer EW. Management of opioid analgesic overdose. N Engl J Med 2012; 367:146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dahan A, Aarts L, Smith TW. Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression. Anesthesiology 2010; 112:226.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clarke SF, Dargan PI, Jones AL. Naloxone in opioid poisoning: walking the tightrope. Emerg Med J 2005; 22:612.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cuss FM, Colaço CB, Baron JH. Cardiac arrest after reversal of effects of opiates with naloxone. Br Med J (Clin Res Ed) 1984; 288:363.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andree RA. Sudden death following naloxone administration. Anesth Analg 1980; 59:782.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Michaelis LL, Hickey PR, Clark TA, Dixon WM. Ventricular irritability associated with the use of naloxone hydrochloride. Two case reports and laboratory assessment of the effect of the drug on cardiac excitability. Ann Thorac Surg 1974; 18:608.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ward S, Corall IM. Hypertension after naloxone. Anaesthesia 1983; 38:1000.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Estilo AE, Cottrell JE. Naloxone, hypertension, and ruptured cerebral aneurysm. Anesthesiology 1981; 54:352.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Azar I, Turndorf H. Severe hypertension and multiple atrial premature contractions following naloxone administration. Anesth Analg 1979; 58:524.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tanaka GY. Letter: Hypertensive reaction to naloxone. JAMA 1974; 228:25.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nath SS, Tripathi M, Pandey C, Rao B. Naloxone-induced pulmonary edema: a potential cause of postoperative morbidity in laparoscopic donor nephrectomy. Indian J Med Sci 2009; 63:72.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Horng HC, Ho MT, Huang CH, et al. Negative pressure pulmonary edema following naloxone administration in a patient with fentanyl-induced respiratory depression. Acta Anaesthesiol Taiwan 2010; 48:155.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brimacombe J, Archdeacon J, Newell S, Martin J. Two cases of naloxone-induced pulmonary oedema--the possible use of phentolamine in management. Anaesth Intensive Care 1991; 19:578.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wride SR, Smith RE, Courtney PG. A fatal case of pulmonary oedema in a healthy young male following naloxone administration. Anaesth Intensive Care 1989; 17:374.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Partridge BL, Ward CF. Pulmonary edema following low-dose naloxone administration. Anesthesiology 1986; 65:709.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prough DS, Roy R, Bumgarner J, Shannon G. Acute pulmonary edema in healthy teenagers following conservative doses of intravenous naloxone. Anesthesiology 1984; 60:485.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taff RH. Pulmonary edema following naloxone administration in a patient without heart disease. Anesthesiology 1983; 59:576.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Osterwalder JJ. Naloxone--for intoxications with intravenous heroin and heroin mixtures--harmless or hazardous? A prospective clinical study. J Toxicol Clin Toxicol 1996; 34:409.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rogers JF, Morrison AL, Nafziger AN, et al. Flumazenil reduces midazolam-induced cognitive impairment without altering pharmacokinetics. Clin Pharmacol Ther 2002; 72:711.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mancuso CE, Tanzi MG, Gabay M. Paradoxical reactions to benzodiazepines: literature review and treatment options. Pharmacotherapy 2004; 24:1177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hughes MA, Glass PS, Jacobs JR. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 1992; 76:334.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dutta A, Sethi N, Sood J, et al. The Effect of Dexmedetomidine on Propofol Requirements During Anesthesia Administered by Bispectral Index-Guided Closed-Loop Anesthesia Delivery System: A Randomized Controlled Study. Anesth Analg 2019; 129:84.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wiinholdt D, Eriksen SAN, Harms LB, et al. Inadequate emergence after non-cardiac surgery-A prospective observational study in 1000 patients. Acta Anaesthesiol Scand 2019; 63:1137.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maheshwari K, Ahuja S, Mascha EJ, et al. Effect of Sevoflurane Versus Isoflurane on Emergence Time and Postanesthesia Care Unit Length of Stay: An Alternating Intervention Trial. Anesth Analg 2020; 130:360.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seo SW, Suh MK, Chin J, Na DL. Mental confusion associated with scopolamine patch in elderly with mild cognitive impairment (MCI). Arch Gerontol Geriatr 2009; 49:204.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Román GC, Jackson RE, Longoria EM, Fisher RE. Scopolamine-induced "cholinergic stress test" in the elderly. Front Pharmacol 2014; 5:182.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg 2010; 111:120.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brull SJ, Murphy GS. Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness. Anesth Analg 2010; 111:129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grosse-Sundrup M, Henneman JP, Sandberg WS, et al. Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study. BMJ 2012; 345:e6329.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fortier LP, McKeen D, Turner K, et al. The RECITE Study: A Canadian Prospective, Multicenter Study of the Incidence and Severity of Residual Neuromuscular Blockade. Anesth Analg 2015; 121:366.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stohl HE, Daher R, Aguirre F, Chen CC. Seizure and mental status change after surgery for pelvic organ prolapse. Int Urogynecol J 2011; 22:1463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nilanont Y, Komoltri C, Saposnik G, et al. The Canadian Neurological Scale and the NIHSS: development and validation of a simple conversion model. Cerebrovasc Dis 2010; 30:120.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Whiteley WN, Wardlaw JM, Dennis MS, Sandercock PA. Clinical scores for the identification of stroke and transient ischaemic attack in the emergency department: a cross-sectional study. J Neurol Neurosurg Psychiatry 2011; 82:1006.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Selim M. Perioperative stroke. N Engl J Med 2007; 356:706.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bateman BT, Schumacher HC, Wang S, et al. Perioperative acute ischemic stroke in noncardiac and nonvascular surgery: incidence, risk factors, and outcomes. Anesthesiology 2009; 110:231.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ng JL, Chan MT, Gelb AW. Perioperative stroke in noncardiac, nonneurosurgical surgery. Anesthesiology 2011; 115:879.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vlisides P, Mashour GA. Perioperative stroke. Can J Anaesth 2016; 63:193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fathi AR, Eshtehardi P, Meier B. Patent foramen ovale and neurosurgery in sitting position: a systematic review. Br J Anaesth 2009; 102:588.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chiappa V, Gonzalez RG, Manian FA, Deshpande V. CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 23-2016. A 46-Year-Old Man with Somnolence after Orthopedic Surgery. N Engl J Med 2016; 375:370.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hewer CL. THE STAGES AND SIGNS OF GENERAL ANAESTHESIA. Br Med J 1937; 2:274.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Card E, Pandharipande P, Tomes C, et al. Emergence from general anaesthesia and evolution of delirium signs in the post-anaesthesia care unit. Br J Anaesth 2015; 115:411.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guenther U, Riedel L, Radtke FM. Patients prone for postoperative delirium: preoperative assessment, perioperative prophylaxis, postoperative treatment. Curr Opin Anaesthesiol 2016; 29:384.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Munk L, Andersen G, Møller AM. Post-anaesthetic emergence delirium in adults: incidence, predictors and consequences. Acta Anaesthesiol Scand 2016; 60:1059.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hernandez BA, Lindroth H, Rowley P, et al. Post-anaesthesia care unit delirium: incidence, risk factors and associated adverse outcomes. Br J Anaesth 2017; 119:288.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aldecoa C, Bettelli G, Bilotta F, et al. European Society of Anaesthesiology evidence-based and consensus-based guideline on postoperative delirium. Eur J Anaesthesiol 2017; 34:192.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berian JR, Zhou L, Russell MM, et al. Postoperative Delirium as a Target for Surgical Quality Improvement. Ann Surg 2018; 268:93.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stamper MJ, Hawks SJ, Taicher BM, et al. Identifying pediatric emergence delirium by using the PAED Scale: a quality improvement project. AORN J 2014; 99:480.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lawlor PG, Gagnon B, Mancini IL, et al. Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med 2000; 160:786.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aouad MT, Zeeni C, Al Nawwar R, et al. Dexmedetomidine for Improved Quality of Emergence From General Anesthesia: A Dose-Finding Study. Anesth Analg 2017.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim SY, Kim JM, Lee JH, et al. Efficacy of intraoperative dexmedetomidine infusion on emergence agitation and quality of recovery after nasal surgery. Br J Anaesth 2013; 111:222.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim DJ, Kim SH, So KY, Jung KT. Effects of dexmedetomidine on smooth emergence from anaesthesia in elderly patients undergoing orthopaedic surgery. BMC Anesthesiol 2015; 15:139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Duan X, Coburn M, Rossaint R, et al. Efficacy of perioperative dexmedetomidine on postoperative delirium: systematic review and meta-analysis with trial sequential analysis of randomised controlled trials. Br J Anaesth 2018; 121:384.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sin JCK, Tabah A, Campher MJJ, et al. The Effect of Dexmedetomidine on Postanesthesia Care Unit Discharge and Recovery: A Systematic Review and Meta-Analysis. Anesth Analg 2022; 134:1229.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bowdle TA, Radant AD, Cowley DS, et al. Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations. Anesthesiology 1998; 88:82.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kleinloog D, Uit den Boogaard A, Dahan A, et al. Optimizing the glutamatergic challenge model for psychosis, using S+ -ketamine to induce psychomimetic symptoms in healthy volunteers. J Psychopharmacol 2015; 29:401.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grace RF. The effect of variable-dose diazepam on dreaming and emergence phenomena in 400 cases of ketamine-fentanyl anaesthesia. Anaesthesia 2003; 58:904.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Avidan MS, Maybrier HR, Abdallah AB, et al. Intraoperative ketamine for prevention of postoperative delirium or pain after major surgery in older adults: an international, multicentre, double-blind, randomised clinical trial. Lancet 2017; 390:267.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Highland KB, Soumoff AA, Spinks EA, et al. Ketamine Administration During Hospitalization Is Not Associated With Posttraumatic Stress Disorder Outcomes in Military Combat Casualties: A Matched Cohort Study. Anesth Analg 2020; 130:402.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maurice-Szamburski A, Auquier P, Viarre-Oreal V, et al. Effect of sedative premedication on patient experience after general anesthesia: a randomized clinical trial. JAMA 2015; 313:916.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schrijver EJM, de Vries OJ, van de Ven PM, et al. Haloperidol versus placebo for delirium prevention in acutely hospitalised older at risk patients: a multi-centre double-blind randomised controlled clinical trial. Age Ageing 2018; 47:48.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neufeld KJ, Yue J, Robinson TN, et al. Antipsychotic Medication for Prevention and Treatment of Delirium in Hospitalized Adults: A Systematic Review and Meta-Analysis. J Am Geriatr Soc 2016; 64:705.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Girard TD, Exline MC, Carson SS, et al. Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness. N Engl J Med 2018; 379:2506.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boncyk CS, Farrin E, Stollings JL, et al. Pharmacologic Management of Intensive Care Unit Delirium: Clinical Prescribing Practices and Outcomes in More Than 8500 Patient Encounters. Anesth Analg 2021; 133:713.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           American Geriatrics Society Expert Panel on Postoperative Delirium in Older Adults. Postoperative delirium in older adults: best practice statement from the American Geriatrics Society. J Am Coll Surg 2015; 220:136.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bitsch M, Foss N, Kristensen B, Kehlet H. Pathogenesis of and management strategies for postoperative delirium after hip fracture: a review. Acta Orthop Scand 2004; 75:378.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scholz AF, Oldroyd C, McCarthy K, et al. Systematic review and meta-analysis of risk factors for postoperative delirium among older patients undergoing gastrointestinal surgery. Br J Surg 2016; 103:e21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Whitlock EL, Vannucci A, Avidan MS. Postoperative delirium. Minerva Anestesiol 2011; 77:448.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dasgupta M, Dumbrell AC. Preoperative risk assessment for delirium after noncardiac surgery: a systematic review. J Am Geriatr Soc 2006; 54:1578.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zaal IJ, Devlin JW, Peelen LM, Slooter AJ. A systematic review of risk factors for delirium in the ICU. Crit Care Med 2015; 43:40.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sharma PT, Sieber FE, Zakriya KJ, et al. Recovery room delirium predicts postoperative delirium after hip-fracture repair. Anesth Analg 2005; 101:1215.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neufeld KJ, Leoutsakos JM, Sieber FE, et al. Outcomes of early delirium diagnosis after general anesthesia in the elderly. Anesth Analg 2013; 117:471.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lepousé C, Lautner CA, Liu L, et al. Emergence delirium in adults in the post-anaesthesia care unit. Br J Anaesth 2006; 96:747.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fritz BA, Kalarickal PL, Maybrier HR, et al. Intraoperative Electroencephalogram Suppression Predicts Postoperative Delirium. Anesth Analg 2016; 122:234.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 93871 Version 25.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21190458" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : General anesthesia, sleep, and coma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3605566" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Anaesthetic-related recovery room complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25668997" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Differential diagnosis of delayed awakening from general anesthesia: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9768776" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Factors affecting discharge time in adult outpatients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29057452" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Is unconsciousness simply the reverse of consciousness?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24905569" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Monitoring (un)consciousness: the implications of a new definition of 'anaesthesia'.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27786358" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Calling the patient's own name facilitates recovery from general anaesthesia: a randomised double-blind trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18633028" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Is synergy the rule? A review of anesthetic interactions producing hypnosis and immobility.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24521189" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Anesthetic pharmacology and perioperative considerations for the end stage liver disease patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24521193" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Anesthetic pharmacology for kidney transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1737461" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Metabolic and anatomic thyroid emergencies: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5338943" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Anaesthesia in untreated myxoedema. Report of two cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/557932" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Anesthesia for untreated hypothyroidism: report of three cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15486397" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Hypothyroidism and failure to wean in patients receiving prolonged mechanical ventilation at a regional weaning center.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23246982" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Severe hypothyroidism presenting as myxedema coma in the postoperative period in a patient taking sunitinib: case report and review of literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22784117" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Management of opioid analgesic overdose.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20010421" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16113176" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Naloxone in opioid poisoning: walking the tightrope.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6419929" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Cardiac arrest after reversal of effects of opiates with naloxone.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7191652" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Sudden death following naloxone administration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4139935" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Ventricular irritability associated with the use of naloxone hydrochloride. Two case reports and laboratory assessment of the effect of the drug on cardiac excitability.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6638430" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Hypertension after naloxone.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7212343" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Naloxone, hypertension, and ruptured cerebral aneurysm.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/574740" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Severe hypertension and multiple atrial premature contractions following naloxone administration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4406136" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Letter: Hypertensive reaction to naloxone.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19359770" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Naloxone-induced pulmonary edema: a potential cause of postoperative morbidity in laparoscopic donor nephrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20864067" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Negative pressure pulmonary edema following naloxone administration in a patient with fentanyl-induced respiratory depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1750644" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Two cases of naloxone-induced pulmonary oedema--the possible use of phentolamine in management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2774157" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : A fatal case of pulmonary oedema in a healthy young male following naloxone administration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3789455" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Pulmonary edema following low-dose naloxone administration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6711858" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Acute pulmonary edema in healthy teenagers following conservative doses of intravenous naloxone.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6650916" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Pulmonary edema following naloxone administration in a patient without heart disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8699555" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Naloxone--for intoxications with intravenous heroin and heroin mixtures--harmless or hazardous? A prospective clinical study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12496752" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Flumazenil reduces midazolam-induced cognitive impairment without altering pharmacokinetics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15460178" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Paradoxical reactions to benzodiazepines: literature review and treatment options.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1539843" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29787410" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : The Effect of Dexmedetomidine on Propofol Requirements During Anesthesia Administered by Bispectral Index-Guided Closed-Loop Anesthesia Delivery System: A Randomized Controlled Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31241184" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Inadequate emergence after non-cardiac surgery-A prospective observational study in 1000 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30882520" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Effect of Sevoflurane Versus Isoflurane on Emergence Time and Postanesthesia Care Unit Length of Stay: An Alternating Intervention Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18834638" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Mental confusion associated with scopolamine patch in elderly with mild cognitive impairment (MCI).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25165458" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Scopolamine-induced "cholinergic stress test" in the elderly.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20442260" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20442261" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23077290" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25902322" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : The RECITE Study: A Canadian Prospective, Multicenter Study of the Incidence and Severity of Residual Neuromuscular Blockade.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21647801" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Seizure and mental status change after surgery for pelvic organ prolapse.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20501997" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : The Canadian Neurological Scale and the NIHSS: development and validation of a simple conversion model.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21402744" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Clinical scores for the identification of stroke and transient ischaemic attack in the emergency department: a cross-sectional study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17301301" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Perioperative stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19194149" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Perioperative acute ischemic stroke in noncardiac and nonvascular surgery: incidence, risk factors, and outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21862923" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Perioperative stroke in noncardiac, nonneurosurgical surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26391795" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Perioperative stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19346525" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Patent foramen ovale and neurosurgery in sitting position: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27464205" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 23-2016. A 46-Year-Old Man with Somnolence after Orthopedic Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20780832" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : THE STAGES AND SIGNS OF GENERAL ANAESTHESIA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25540068" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Emergence from general anaesthesia and evolution of delirium signs in the post-anaesthesia care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26905874" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Patients prone for postoperative delirium: preoperative assessment, perioperative prophylaxis, postoperative treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26968337" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Post-anaesthetic emergence delirium in adults: incidence, predictors and consequences.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28854553" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Post-anaesthesia care unit delirium: incidence, risk factors and associated adverse outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28187050" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : European Society of Anaesthesiology evidence-based and consensus-based guideline on postoperative delirium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28742701" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Postoperative Delirium as a Target for Surgical Quality Improvement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24674794" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Identifying pediatric emergence delirium by using the PAED Scale: a quality improvement project.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10737278" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29293178" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Dexmedetomidine for Improved Quality of Emergence From General Anesthesia: A Dose-Finding Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23524149" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Efficacy of intraoperative dexmedetomidine infusion on emergence agitation and quality of recovery after nasal surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26446479" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Effects of dexmedetomidine on smooth emergence from anaesthesia in elderly patients undergoing orthopaedic surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30032877" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Efficacy of perioperative dexmedetomidine on postoperative delirium: systematic review and meta-analysis with trial sequential analysis of randomised controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35085107" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : The Effect of Dexmedetomidine on Postanesthesia Care Unit Discharge and Recovery: A Systematic Review and Meta-Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9447860" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25693889" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Optimizing the glutamatergic challenge model for psychosis, using S+ -ketamine to induce psychomimetic symptoms in healthy volunteers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12911367" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : The effect of variable-dose diazepam on dreaming and emergence phenomena in 400 cases of ketamine-fentanyl anaesthesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28576285" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Intraoperative ketamine for prevention of postoperative delirium or pain after major surgery in older adults: an international, multicentre, double-blind, randomised clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31335405" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Ketamine Administration During Hospitalization Is Not Associated With Posttraumatic Stress Disorder Outcomes in Military Combat Casualties: A Matched Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25734733" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Effect of sedative premedication on patient experience after general anesthesia: a randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28985255" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Haloperidol versus placebo for delirium prevention in acutely hospitalised older at risk patients: a multi-centre double-blind randomised controlled clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27004732" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Antipsychotic Medication for Prevention and Treatment of Delirium in Hospitalized Adults: A Systematic Review and Meta-Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30346242" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33433117" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Pharmacologic Management of Intensive Care Unit Delirium: Clinical Prescribing Practices and Outcomes in More Than 8500 Patient Encounters.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25535170" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Postoperative delirium in older adults: best practice statement from the American Geriatrics Society.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15370579" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Pathogenesis of and management strategies for postoperative delirium after hip fracture: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26676760" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Systematic review and meta-analysis of risk factors for postoperative delirium among older patients undergoing gastrointestinal surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21483389" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Postoperative delirium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17038078" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Preoperative risk assessment for delirium after noncardiac surgery: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25251759" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : A systematic review of risk factors for delirium in the ICU.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16192548" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Recovery room delirium predicts postoperative delirium after hip-fracture repair.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23757476" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Outcomes of early delirium diagnosis after general anesthesia in the elderly.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16670111" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Emergence delirium in adults in the post-anaesthesia care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26418126" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Intraoperative Electroencephalogram Suppression Predicts Postoperative Delirium.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
